Nanotechnology-medicated therapeutic HPV DNA vaccines (2018)

Despite the efficacy of prophylactic vaccines, it will take decades to achieve the full impact on reducing the incidence of human papillomavirus (HPV)-associated cancers. Thus, development of therapeutic HPV vaccines is crucial to cure patients with established HPV infections. DNA vaccines are a desired option but their potency is limited. This project aims to develop a novel HPV DNA vaccine nano-platform with improved efficacy, providing next generation of potent therapeutic HPV DNA vaccines.
Grant type:
UQ Early Career Researcher
  • NHMRC Early Career Fellow
    The University of Queensland Diamantina Institute
    Faculty of Medicine
    Affiliate Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
University of Queensland